Cargando…
For decades against the mainstream − From erythropoietin and hypoxia as novel treatment strategies to deep phenotyping in neuropsychiatric disorders
Autor principal: | Ehrenreich, Hannelore |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613706/ https://www.ncbi.nlm.nih.gov/pubmed/36170796 http://dx.doi.org/10.1016/j.psychres.2022.114854 |
Ejemplares similares
-
Erythropoietin improves operant conditioning and stability of cognitive performance in mice
por: El-Kordi, Ahmed, et al.
Publicado: (2009) -
Erythropoietin as candidate for supportive treatment of severe COVID-19
por: Ehrenreich, Hannelore, et al.
Publicado: (2020) -
Addressing the ‘hypoxia paradox’ in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues
por: Begemann, Martin, et al.
Publicado: (2021) -
Functional hypoxia drives neuroplasticity and neurogenesis via brain erythropoietin
por: Wakhloo, Debia, et al.
Publicado: (2020) -
Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder
por: Miskowiak, Kamilla W, et al.
Publicado: (2010)